skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Science & Technology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Modeling collective motion: variations on the Vicsek model
Modeling collective motion: variations on the Vicsek model
Material Type:
Artigo 		Adicionar ao Meu Espaço

Modeling collective motion: variations on the Vicsek model

Chaté, H. ; Ginelli, F. ; Grégoire, G. ; Peruani, F. ; Raynaud, F.

The European physical journal. B, Condensed matter physics, 2008-08, Vol.64 (3-4), p.451-456 [Periódico revisado por pares]

Berlin/Heidelberg: Springer-Verlag

Texto completo disponível

Citações Citado por
2
Progress in the Preclinical Discovery and Clinical Development of Class I and Dual Class I/IV Phosphoinositide 3-Kinase (PI3K) Inhibitors
Progress in the Preclinical Discovery and Clinical Development of Class I and Dual Class I/IV Phosphoinositide 3-Kinase (PI3K) Inhibitors
Material Type:
Artigo 		Adicionar ao Meu Espaço

Progress in the Preclinical Discovery and Clinical Development of Class I and Dual Class I/IV Phosphoinositide 3-Kinase (PI3K) Inhibitors

Shuttleworth, S J ; Silva, F A ; Cecil, A R L ; Tomassi, C D ; Hill, T J ; Raynaud, F I ; Clarke, P A ; Workman, P

Current medicinal chemistry, 2011-06, Vol.18 (18), p.2686-2714 [Periódico revisado por pares]

United Arab Emirates: Bentham Science Publishers Ltd

Texto completo disponível

Citações Citado por
3
A phase I dose-escalation study of enzalutamide in combination with the AKT inhibitor AZD5363 (capivasertib) in patients with metastatic castration-resistant prostate cancer
A phase I dose-escalation study of enzalutamide in combination with the AKT inhibitor AZD5363 (capivasertib) in patients with metastatic castration-resistant prostate cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase I dose-escalation study of enzalutamide in combination with the AKT inhibitor AZD5363 (capivasertib) in patients with metastatic castration-resistant prostate cancer

Kolinsky, M.P. ; Rescigno, P. ; Bianchini, D. ; Zafeiriou, Z. ; Mehra, N. ; Mateo, J. ; Michalarea, V. ; Riisnaes, R. ; Crespo, M. ; Figueiredo, I. ; Miranda, S. ; Nava Rodrigues, D. ; Flohr, P. ; Tunariu, N. ; Banerji, U. ; Ruddle, R. ; Sharp, A. ; Welti, J. ; Lambros, M. ; Carreira, S. ; Raynaud, F.I. ; Swales, K.E. ; Plymate, S. ; Luo, J. ; Tovey, H. ; Porta, N. ; Slade, R. ; Leonard, L. ; Hall, E. ; de Bono, J.S.

Annals of oncology, 2020-05, Vol.31 (5), p.619-625 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Implication of calpain in neuronal apoptosis. A possible regulation of Alzheimer's disease
Implication of calpain in neuronal apoptosis. A possible regulation of Alzheimer's disease
Material Type:
Artigo 		Adicionar ao Meu Espaço

Implication of calpain in neuronal apoptosis. A possible regulation of Alzheimer's disease

Raynaud, F ; Marcilhac, A

The FEBS journal, 2006-08, Vol.273 (15), p.3437-3443 [Periódico revisado por pares]

England

Texto completo disponível

Citações Citado por
5
Fit-for-purpose biomarker method validation for application in clinical trials of anticancer drugs
Fit-for-purpose biomarker method validation for application in clinical trials of anticancer drugs
Material Type:
Artigo 		Adicionar ao Meu Espaço

Fit-for-purpose biomarker method validation for application in clinical trials of anticancer drugs

CUMMINGS, J ; RAYNAUD, F ; JONES, L ; SUGAR, R ; DIVE, C

British journal of cancer, 2010-10, Vol.103 (9), p.1313-1317 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
6
Selective FLT3 inhibition of FLT3-ITD+ acute myeloid leukaemia resulting in secondary D835Y mutation: a model for emerging clinical resistance patterns
Selective FLT3 inhibition of FLT3-ITD+ acute myeloid leukaemia resulting in secondary D835Y mutation: a model for emerging clinical resistance patterns
Material Type:
Artigo 		Adicionar ao Meu Espaço

Selective FLT3 inhibition of FLT3-ITD+ acute myeloid leukaemia resulting in secondary D835Y mutation: a model for emerging clinical resistance patterns

MOORE, A. S ; FAISAL, A ; MIRABELLA, F ; SWANSBURY, J ; PEARSON, Adj ; WORKMAN, P ; BLAGG, J ; RAYNAUD, F. I ; ECCLES, S. A ; LINARDOPOULOS, S ; GONZALEZ DE CASTRO, D ; BAVETSIAS, V ; SUN, C ; ATRASH, B ; VALENTI, M ; DE HAVEN BRANDON, A ; AVERY, S ; MAIR, D

Leukemia, 2012-07, Vol.26 (7), p.1462-1470 [Periódico revisado por pares]

Avenel, NJ: Nature Publishing Group

Texto completo disponível

Citações Citado por
7
A phase I trial of the selective oral cyclin-dependent kinase inhibitor seliciclib (CYC202; -Roscovitine), administered twice daily for 7 days every 21 days
A phase I trial of the selective oral cyclin-dependent kinase inhibitor seliciclib (CYC202; -Roscovitine), administered twice daily for 7 days every 21 days
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase I trial of the selective oral cyclin-dependent kinase inhibitor seliciclib (CYC202; -Roscovitine), administered twice daily for 7 days every 21 days

BENSON, C ; WHITE, J ; CASSIDY, J ; GIANELLA-BORRADORI, A ; JUDSON, I ; TWELVES, C ; DE BONO, J ; O'DONNELL, A ; RAYNAUD, F ; CRUICKSHANK, C ; MCGRATH, H ; WALTON, M ; WORKMAN, P ; KAYE, S

British journal of cancer, 2007-01, Vol.96 (1), p.29-37 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
8
Vistusertib (dual m-TORC1/2 inhibitor) in combination with paclitaxel in patients with high-grade serous ovarian and squamous non-small-cell lung cancer
Vistusertib (dual m-TORC1/2 inhibitor) in combination with paclitaxel in patients with high-grade serous ovarian and squamous non-small-cell lung cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Vistusertib (dual m-TORC1/2 inhibitor) in combination with paclitaxel in patients with high-grade serous ovarian and squamous non-small-cell lung cancer

Basu, B. ; Krebs, M.G. ; Sundar, R. ; Wilson, R.H. ; Spicer, J. ; Jones, R. ; Brada, M. ; Talbot, D.C. ; Steele, N. ; Ingles Garces, A.H. ; Brugger, W. ; Harrington, E.A. ; Evans, J. ; Hall, E. ; Tovey, H. ; de Oliveira, F.M. ; Carreira, S. ; Swales, K. ; Ruddle, R. ; Raynaud, F.I. ; Purchase, B. ; Dawes, J.C. ; Parmar, M. ; Turner, A.J. ; Tunariu, N. ; Banerjee, S. ; de Bono, J.S. ; Banerji, U.

Annals of oncology, 2018-09, Vol.29 (9), p.1918-1925 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
Preclinical pharmacokinetics and metabolism of a novel prototype DNA-PK inhibitor NU7026
Preclinical pharmacokinetics and metabolism of a novel prototype DNA-PK inhibitor NU7026
Material Type:
Artigo 		Adicionar ao Meu Espaço

Preclinical pharmacokinetics and metabolism of a novel prototype DNA-PK inhibitor NU7026

NUTLEY, B. P ; SMITH, N. F ; HAYES, A ; KELLAND, L. R ; BRUNTON, L ; GOLDING, B. T ; SMITH, G. C. M ; MARTIN, N. M. B ; WORKMAN, P ; RAYNAUD, F. I

British journal of cancer, 2005-10, Vol.93 (9), p.1011-1018 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
10
Shank3-Rich2 interaction regulates AMPA receptor recycling and synaptic long-term potentiation
Shank3-Rich2 interaction regulates AMPA receptor recycling and synaptic long-term potentiation
Material Type:
Artigo 		Adicionar ao Meu Espaço

Shank3-Rich2 interaction regulates AMPA receptor recycling and synaptic long-term potentiation

Raynaud, Fabrice ; Janossy, Andrea ; Dahl, Janine ; Bertaso, Federica ; Perroy, Julie ; Varrault, Annie ; Vidal, Michel ; Worley, Paul F ; Boeckers, Tobias M ; Bockaert, Joël ; Marin, Philippe ; Fagni, Laurent ; Homburger, Vincent

The Journal of neuroscience, 2013-06, Vol.33 (23), p.9699-9715 [Periódico revisado por pares]

United States: Society for Neuroscience

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (473)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (482)
  2. Anais de Congresso  (42)
  3. Book Chapters  (1)
  4. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1981  (24)
  2. 1981Até1991  (46)
  3. 1992Até2002  (158)
  4. 2003Até2014  (208)
  5. Após 2014  (91)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (509)
  2. Japonês  (85)
  3. Francês  (22)
  4. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.